To access this element change to forms mode OFF

Current Grant Opportunity View - GO5279

MRFF – PPHRI – 2021 Optimising the Clinical Use of Immunoglobulins Grant Opportunity

Contact Details

NHMRC Research Help Centre

:
1800 500 983

:

:

GO ID:
GO5279
Agency:
National Health and Medical Research Council (NHMRC)
Close Date & Time:
2-Mar-2022 5:00 pm (ACT Local Time)
Show close time for other time zones
Co-sponsored with:
Department of Health
Primary Category:
231013 - Medical Research
Publish Date:
20-Dec-2021
Location:
ACT, NSW, VIC, SA, WA, QLD, NT, TAS
Selection Process:
Targeted or Restricted Competitive

Description:

The objective of opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects.

  • Stream 1: conduct a randomised trial to compare different regimens for a therapeutic immunoglobulin in immunoglobulin responders following haematological malignancy.
  • Stream 2: conduct a randomised trial to compare different regimens for a therapeutic immunoglobulin in immunoglobulin responders whose acquired hypogammaglobulinaemia is not due to haematological malignancy.
  • Stream 3: conduct a randomised trial to compare different regimens for a therapeutic immunoglobulin (e.g. varied dosage, duration, route of administration) against each other and/or other therapeutic options (e.g. alternative or concurrent therapies) for myasthenia gravis or chronic inflammatory demyelinating polyneuropathy, to inform their most cost-effective use.
  • Stream 4: build the evidence base to inform the cost-effective clinical use of immunoglobulin in Australia. This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health.

Further information on the Medical Research Future Fund is available from the Department of Health website.

Eligibility:

Applications will only be accepted from NHMRC approved MRFF Eligible Organisations. A list of NHMRC approved MRFF Eligible Organisations is available from the GrantConnect GO Documents and from the MRFF Eligible Organisations Institutions list on the NHMRC website.

Applications must satisfy all the requirements set out in the Medical Research Future Fund (MRFF) – Preventive and Public Health Research Initiative – 2021 Optimising the Clinical Use of Immunoglobulins Grant Opportunity guidelines

Grant Activity Timeframe:

Streams 1 to 3 – 5 years

Stream 4 – 3 years

Total Amount Available (AUD):

$14,000,000.00

Estimated Grant Value (AUD):

From $0.00 to $4,000,000.00

Instructions for Application Submission:

Applicants are advised to read the Grant Guidelines thoroughly and liaise with the Eligible Organisation that will submit the application to identify any specific requirements that the Institution might have.

Applications must be submitted electronically using NHMRC’s online granting system (Sapphire).

Other Instructions:

Minimum Data closes at 5:00 pm (ACT Local Time) on 16 Feb 2022

Questions should be submitted no later than 1:00 pm (ACT Local Time) on 23 Feb 2022.

For all streams, there is no maximum grant amount but grants cannot exceed the amount of available funds in the relevant stream.

Stream one - $4 000 000 total available

Stream two - $4 000 000 total available

Stream three - $4 000 000 total available

Stream four - $2 000 000 total available

Addenda Available:

Contact Details

NHMRC Research Help Centre

:
1800 500 983

:

: